KdT Ventures – Medium

KdT Ventures

Expanding the Drug Delivery Toolbox

Today our ability to treat many diseases is limited only by our ability to effectively deliver genetic medicines.

9 min readSep 15, 2022

--

Expanding the Drug Delivery Toolbox

--

KdT Ventures

State of the Market: The Goalposts

Before I start, let me get two things out of the way. First, in no way am I the caller of market tops and bottoms — and that’s not the…

4 min readMay 9, 2022

--

--

KdT Ventures

The Bioproduction Battle

The globalization that began during the 1990s and flourished into this millennia reshaped aspects of our lives in ways we are only now…

7 min readMay 2, 2022

--

The Bioproduction Battle

--

KdT Ventures

How health insurance DAOs can break up RWD silos

KdT has recently been exploring alternative data sharing incentive structures, since as a firm we believe the greatest advancements in…

11 min readFeb 14, 2022

--

How health insurance DAOs can break up RWD silos

--

KdT Ventures

Zymergen: A Cautionary Tale

As we continue to digest the news from Zymergen and its reverberations across the Synthetic Biology ecosystem, we wanted to take a moment…

2 min readAug 5, 2021

--

Zymergen: A Cautionary Tale

--

KdT Ventures

The World in a Grain of Sand

Content is king (or so my kids tell me). We would like to be able to say that we have a grand plan in mind behind launching curated content…

2 min readMay 13, 2021

--

The World in a Grain of Sand

--

KdT Ventures

What $50M in New Capital Means for Entrepreneurs

Today we’re announcing the closing of our $50M Fund II for KdT Ventures. With the announcement, one important aspect is obvious: with this…

2 min readMar 23, 2021

--

What $50M in New Capital Means for Entrepreneurs

--

KdT Ventures

Partnering and Focus

N.B.- As a reminder, we are a seed-stage firm so our views relate to companies at that seed stage.

3 min readJan 26, 2021

--

Partnering and Focus

--

KdT Ventures

The Golden Age of Microfluidics?

Lately, it feels like a disproportionately large number of companies we have seen at KdT deploy or manipulate microfluidic technology of…

2 min readJan 6, 2021

--

The Golden Age of Microfluidics?

--

KdT Ventures

How Platforms Can Think Intelligently About Early Deal Structure

Before jumping in headfirst, it’s important to acknowledge relevant qualifiers:

5 min readJun 29, 2020

--

How Platforms Can Think Intelligently About Early Deal Structure

--

KdT Ventures

KdT Ventures

KdT is the standard for early-stage science venture investing. We help founders and their companies re-architect the world at a molecular level.

Help
Status
About
Careers
Blog
Privacy
Terms
Text to speech
Teams